Are you building an innovative and emerging life science or biotech start-up?
Then now is your opportunity to accelerate your research and transform it into meaningful value for patients by applying for an Astellas Golden Ticket.
We are offering up to two Golden Tickets for pioneering scientific research that complements Astellas’ interest in all areas of innovation and particularly our R&D Focus Areas: oncology, immunology/allergy, neuromuscular disorders, sensory disorders, and neuroscience.
Astellas Golden Ticket winners will gain access to:
One year’s priority admission or renewal to MBC BioLabs state-of-the-art lab and Fast Track core facility
Astellas’ R&D scientists, business leaders and global network of partners
Submit your non-confidential company presentation to flavia.nachbar@mbcbiolabs.com by Friday October 11, 2019, for your chance to turn your innovation into real business.
Disclaimer: The decision to award any Golden Ticket, and the assessments underlying such decision, are solely within the judgment of Astellas and MBC BioLabs, and are not subject to any objection or appeal
